Holt, 15,227 patient budesonide prophylaxis study: 32% fewer cases [p=0.03] https://c19p.org/holtu
copied to clipboard
Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK)
et al., Thorax, doi:10.1136/thoraxjnl-2021-217487, COVIDENCE UK, NCT04330599 (history)
Prospective survey-based study with 15,227 people in the UK, showing lower risk of COVID-19 cases with vitamin A, vitamin D, zinc, selenium, probiotics, and inhaled corticosteroids; and higher risk with metformin and vitamin C. Statistical significance was not reached for any of these. Except for vitamin D, the results for treatments we follow were only adjusted for age, sex, duration of participation, and test frequency. NCT04330599 (history). COVIDENCE UK.
|
risk of case, 32.0% lower, OR 0.68, p = 0.03, treatment 913, control 14,314, adjusted per study, inhaled corticosteroids, minimally adjusted, group sizes approximated, RR approximated with OR.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
This study is excluded in the after exclusion results of meta
analysis:
significant unadjusted confounding possible.
Holt et al., 30 Mar 2021, prospective, United Kingdom, peer-reviewed, 34 authors, study period 1 May, 2020 - 5 February, 2021, trial NCT04330599 (history) (COVIDENCE UK).
Contact:
a.martineau@qmul.ac.uk.
holt
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.